Actuate Therapeutics ACTU
NASDAQ ACTU
$0.60 -0.01 (-2.04%)
As of: Oct 21, 2026 · 10:57 AM EDT

Actuate Therapeutics (ACTU) Total Debt (2024)

Updated

Actuate Therapeutics (ACTU) recorded Total Debt of $6.9 million in Q2 2024.

Analysis

Actuate Therapeutics (ACTU) Total Debt (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,131.80 Bn 1,100.39 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 614.01 Bn 532.53 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.59 Bn 476.70 Bn 12.70 Bn 70.82 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 297.81 Bn 261.80 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.50 Bn 235.19 Bn 12.86 Bn 32.35 Bn
7 Amgen 236.24 Bn 191.64 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.15 Bn 165.35 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.16 Bn 116.81 Bn 10.94 Bn 63.19 Bn
10 Actuate Therapeutics 14.41 Mn -26.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 6.90 Mn
API Access

Actuate Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=ACTU&period=max&api_key=YOUR_API_KEY